EIX
61
8
CNP
59
17
DNB
72
4
BXP
39
5
ADBE
50
3
GM
55
6
BAX
38
2
APH
53
3
CHRW
53
2
ROK
46
3
NDAQ
46
2
SPG
45
2
GD
42
4
STT
48
4
SHW
42
5
CF
47
5
AIG
38
5
NI
63
5
KIM
58
2
FAST
41
7
EIX
61
8
CNP
59
17
DNB
72
4
BXP
39
5
ADBE
50
3
GM
55
6
BAX
38
2
APH
53
3
CHRW
53
2
ROK
46
3
NDAQ
46
2
SPG
45
2
GD
42
4
STT
48
4
SHW
42
5
CF
47
5
AIG
38
5
NI
63
5
KIM
58
2
FAST
41
7
Financhill
Back

Cassava Sciences 10K Form

Sell
19

SAVA
Cassava Sciences

Last Price:
$2.49
Seasonality Move:
34.39%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2020-08-12 10Q SAVA/Cassava Sciences Quarterly
2020-05-06 10Q SAVA/Cassava Sciences Quarterly
2020-03-26 10K SAVA/Cassava Sciences Annual
2019-10-29 10Q SAVA/Cassava Sciences Quarterly
2019-08-12 10Q SAVA/Cassava Sciences Quarterly
2019-05-02 10Q SAVA/Cassava Sciences Quarterly

Receive SAVA News And Ratings

See the #1 stock for the next 7 days that we like better than SAVA

SAVA Financial Statistics

Sales & Book Value

Annual Sales: $41.1M
Cash Flow: $-18.3M
Price / Cash Flow: 0
Annual Sales: $3.47
Price / Book: 0.68

Profitability

EPS (TTM): -1.38000
Net Income (TTM): $-17.7M
Gross Margin: $20.6M
Return on Equity: 0%
Return on Assets: 0%

Cassava Sciences Earnings Forecast

Key Cassava Sciences Financial Ratios

  • The Gross Profit Margin over the past 11 years for SAVA is 100.00%.
  • The Selling, General & Administrative Expenses for SAVA have been equal to 11.76% of Gross Profit Margin.
  • Per Share Earnings over the last 25 years have been positive in 10 years.

Cassava Sciences Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: SAVA
CUSIP: 14817C
Website: cassavasciences.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

SAVA Technical Analysis vs Fundamental Analysis

Sell
19
Cassava Sciences (SAVA) is a Sell

Is Cassava Sciences a Buy or a Sell?

  • Cassava Sciences stock is rated a Sell
    The current Cassava Sciences [SAVA] share price is $2.36. The Score for SAVA is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.